| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |